A | Agilent Technologies, Inc. | [NYSE]
IndexS&P 500 P/E26.52 EPS (ttm)4.54 Insider Own0.30% Shs Outstand296.00M Perf Week-6.56%
Market Cap35.33B Forward P/E19.56 EPS next Y6.16 Insider Trans-7.21% Shs Float294.89M Perf Month-9.63%
Income1.35B PEG2.27 EPS next Q1.36 Inst Own90.70% Short Float / Ratio1.77% / 3.06 Perf Quarter-15.30%
Sales7.04B P/S5.02 EPS this Y6.10% Inst Trans-3.29% Short Interest5.22M Perf Half Y-22.48%
Book/sh18.95 P/B6.35 EPS next Y9.55% ROA11.80% Target Price145.81 Perf Year0.03%
Cash/sh- P/C- EPS next 5Y11.66% ROE23.70% 52W Range112.52 - 160.26 Perf YTD-19.53%
Dividend0.90 P/FCF45.83 EPS past 5Y14.80% ROI16.90% 52W High-24.86% Beta1.05
Dividend %0.75% Quick Ratio1.50 Sales past 5Y8.90% Gross Margin54.60% 52W Low7.02% ATR3.54
Employees18300 Current Ratio2.10 Sales Q/Q4.90% Oper. Margin23.00% RSI (14)28.59 Volatility3.05% 2.12%
OptionableYes Debt/Eq0.53 EPS Q/Q26.90% Profit Margin17.80% Rel Volume1.22 Prev Close119.49
ShortableYes LT Debt/Eq0.49 EarningsMay 23 AMC Payout19.60% Avg Volume1.70M Price120.42
Recom2.00 SMA20-6.99% SMA50-9.80% SMA200-13.87% Volume2,079,416 Change0.78%
Date Action Analyst Rating Change Price Target Change
May-24-23Reiterated Wells Fargo Overweight $170 → $160
May-24-23Reiterated TD Cowen Outperform $168 → $145
May-24-23Reiterated SVB Securities Outperform $170 → $145
May-24-23Reiterated Stifel Hold $153 → $135
May-24-23Reiterated Robert W. Baird Outperform $174 → $144
May-24-23Reiterated Evercore ISI Outperform $150 → $126
May-24-23Reiterated Credit Suisse Outperform $170 → $160
May-24-23Reiterated Citigroup Neutral $150 → $130
May-24-23Reiterated BofA Securities Buy $164 → $144
May-24-23Reiterated Barclays Equal Weight $140 → $135
May-26-23 03:56PM
May-24-23 04:16PM
04:11PM
04:00PM
01:17PM
01:01PM Loading…
01:01PM
12:55PM
12:55PM
11:15AM
10:34AM
09:00AM
06:56AM
04:07AM
May-23-23 07:48PM
05:25PM
04:05PM Loading…
04:05PM
03:38PM
May-22-23 06:00PM
May-21-23 03:00PM
May-19-23 11:08AM
08:46AM
08:30AM
May-18-23 09:25PM
12:14PM
09:39AM
08:32AM
07:24AM
May-17-23 03:57PM
07:16AM
May-16-23 06:00PM
02:47PM Loading…
02:47PM
11:52AM
11:35AM
10:00AM
09:00AM
08:25AM
07:22AM
May-15-23 01:17PM
12:58PM
12:34PM
08:52AM
07:24AM
May-12-23 02:05PM
02:04PM
11:32AM
11:13AM
May-11-23 10:10AM
09:55AM
07:32AM
May-10-23 06:00PM
12:20PM
12:12PM
11:42AM
May-09-23 06:05PM
01:26PM
10:31AM
10:20AM
09:56AM
May-08-23 03:15PM
11:55AM
11:45AM
11:20AM
May-05-23 02:38PM
02:35PM
02:13PM
02:00PM
01:37PM
01:33PM
01:27PM
05:00AM
May-04-23 03:05PM
01:13PM
01:10PM
12:11PM
08:56AM
08:00AM
07:25AM
May-03-23 06:00PM
02:57PM
02:52PM
May-02-23 02:15PM
01:26PM
May-01-23 12:10PM
Apr-27-23 06:00PM
02:19PM
Apr-26-23 01:05PM
08:55AM
Apr-25-23 06:09AM
Apr-24-23 06:15PM
Apr-20-23 11:32AM
10:27AM
Apr-19-23 11:47AM
Apr-14-23 10:48AM
08:00AM
Apr-13-23 11:02AM
08:29AM
Apr-12-23 08:00AM
Apr-08-23 10:49AM
Apr-05-23 10:01AM
Apr-03-23 11:52AM
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ancher-Jensen HenrikSr Vice PresidentDec 14Sale155.7829,5004,595,51070,793Dec 15 12:22 PM
Grau DominiqueSenior Vice PresidentDec 13Sale159.204,000636,80092,379Dec 15 12:20 PM
MCDONNELL PADRAIGSr. Vice PresidentDec 13Sale160.00672107,52015,529Dec 15 12:21 PM
KOH BOON HWEEDirectorDec 06Sale152.2113,0001,978,69257,752Dec 08 11:31 AM
Thaysen JacobSr. Vice PresidentDec 01Sale155.653,235503,52884,464Dec 02 01:45 PM
Thaysen JacobSr. Vice PresidentNov 30Sale154.639,7001,499,91287,699Dec 02 01:45 PM
Gonsalves RodneyV.P., Corporate ControllerNov 23Sale156.204,634723,83128,447Nov 28 03:47 PM
FIELDS HEIDIDirectorNov 23Sale155.843,635566,48254,484Nov 28 03:47 PM
McMullen Michael R.CEO and PresidentNov 22Option Exercise40.80128,7265,252,021389,417Nov 23 01:53 PM
McMullen Michael R.CEO and PresidentNov 22Sale155.73128,72620,046,500260,691Nov 23 01:53 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 22Sale153.907,5451,161,17646,499Nov 23 01:54 PM
MCDONNELL PADRAIGSr. Vice PresidentNov 22Sale153.212,746420,71516,201Nov 23 01:51 PM
McMullen Michael R.CEO and PresidentNov 16Option Exercise40.806,775276,420277,671Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 16Sale148.196,7751,003,987270,896Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 09Option Exercise40.806,775276,420198,133Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 09Sale138.316,775937,050191,358Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 02Option Exercise40.806,775276,420198,133Nov 04 10:54 AM
McMullen Michael R.CEO and PresidentNov 02Sale140.616,775952,633191,358Nov 04 10:54 AM
Tang MichaelSVP, General Counsel, and Sec.Nov 01Sale139.503,600502,20043,280Nov 03 09:52 AM
McMullen Michael R.CEO and PresidentOct 26Option Exercise40.806,775276,420198,133Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 26Sale134.436,775910,763191,358Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 19Option Exercise40.806,775276,420198,133Oct 21 05:01 PM
McMullen Michael R.CEO and PresidentOct 19Sale130.116,775881,495191,358Oct 21 05:01 PM
MCDONNELL PADRAIGSr. Vice PresidentSep 28Sale122.892,103258,43813,217Sep 30 10:34 AM
Thaysen JacobSr. Vice PresidentSep 09Sale137.455,839802,57182,934Sep 13 10:19 AM
MCDONNELL PADRAIGSr. Vice PresidentSep 08Sale134.332,506336,64115,320Sep 09 03:05 PM
MCDONNELL PADRAIGSr. Vice PresidentJun 30Sale118.621,000118,62517,826Jul 01 02:48 PM
Thaysen JacobSr. Vice PresidentJun 02Sale127.435,879749,17988,737Jun 06 01:26 PM